"რუსთავის ცენტრალური საავადმყოფო"

During the past decade, Rustavi Central Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rustavi Central Hospital" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rustavi Central Hospital" are "Ischemic Stroke" (3 trials), "Community-acquired Pneumonia" (1 trials) and "Staphylococcus Aureus Bacteremia" (1 trials). Many other conditions were trialed in "Rustavi Central Hospital" in a lesser frequency.

Most popular intervention types in "Rustavi Central Hospital" are "Device" (3 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active Sphenopalatine Ganglion (SPG) Stimulation" (1 trials), "Ceftobiprole medocaril" (1 trials), "Daptomycin" (1 trials), "ISS SPG stimulation" (1 trials) and "Normal Saline Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rustavi Central Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Rustavi Central Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rustavi Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rustavi Central Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".